SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-038032
Filing Date
2019-08-07
Accepted
2019-08-07 07:15:24
Documents
3
Period of Report
2019-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv526482_8k.htm 8-K 23385
2 EXHIBIT 99.1 tv526482_ex99-1.htm EX-99.1 105743
3 GRAPHIC logo_001.jpg GRAPHIC 2324
  Complete submission text file 0001144204-19-038032.txt   133684
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35668 | Film No.: 191003812
SIC: 2834 Pharmaceutical Preparations